Complement 4 levels as early predictors of poor response to surfactant therapy in respiratory distress syndrome

American Journal of Perinatology

Volumn 22, Issue 3, 2005, Pages 149-154

  Türker, Gülcan ^a   Köksal, Nilgün ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Complement 4; Respiratory distress syndrome; Surfactant therapy

Indexed keywords

C REACTIVE PROTEIN; CARBON DIOXIDE; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C4; CORTICOSTEROID; OXYGEN; SURFACTANT;

ARTICLE; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MORTALITY; NEWBORN; OXYGEN TENSION; PREDICTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; ROC CURVE; TREATMENT OUTCOME;

BIOLOGICAL PRODUCTS; COMPLEMENT C3C; COMPLEMENT C4; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 17844367571     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865021     Document Type: Article

References (16)

1. Weigelt JA, Chenoweth DE, Borman KR, Norcross JF. Complement and the severity of pulmonary failure. J Trauma 1988;28:1013-1019
2. Saugstad O, Buo L, Johansen H, Roise O, Aasen A. Activation of the plasma kallikrein-kinin system in respiratory distress syndrome. Pediatr Res 1992;32:431-435
3. Brus F, van Oeveren W, Okken A, Oetomo SB. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1994;36:647-653
4. Brus F, van Oeveren W, Okken A, Oetomo SB. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1996;39:456-463
5. Wagner MH, Sonntag J, Strauss E, Obladen M. Contact activation related to surfactant response in respiratory distress syndrome. Pediatr Res 1999;45:14-18
6. Sonntag J, Stiller B, Walka MM, Maier RF. Anaphylotoxins in fresh-frozen plasma. Transfusion 1997;37:798-803
7. Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol 1973;1:145-152
8. Segerer H, Stevens P, Schadow B, et al. Surfactant substitution in ventilated very low birth weight infants: factors related to response types. Pediatr Res 1991;30:591-596
9. Soldin SJ, Hicks JM, Bailey J, Beatey J, Cook JF. Pediatric reference ranges for complement factors C3 and C4. Clin Chem 1998;44:A14
10. Schrod L, Frauendienst EG, Von Stockhausen HB, Kirschfink M. Complement fragment C3a in plasma of asphyxiated neonates. Eur J Pediatr 1992;151:688-692
11. Zilow EP, Hauck W, Linderkamp O, Zilow G. Alternative pathway activation of the complement system in preterm infants with early onset infection. Pediatr Res 1997;41:334-339
12. Sonntag J, Wagner MH, Strauss E, Obladen M. Complement and contact activation in term newborns after fetal acidosis. Arch Dis Child Fetal Neonatal Ed 1998;78F:125-128
13. Groneck P, Oppermann M, Speer CP. Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infantsat risk for chronic lung disease and effect of dexamethasone treatment. Pediatr Res 1993;34:586-590
14. Carvalho AC, Demarinis S, Scott CF, Silver LD, Schamaier AH, Colman RW. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 1980;112:270-277
15. Hammerschmidt DE, Hudson LD, Weaver LJ, Craddock PR, Jacob HS. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome: pathophysiological relevance and possible prognostic value. Lancet 1980;8175:947-949
16. Royall JA, Levin DL. Adult respiratory distress syndrome in pediatric patients. I: Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr 1988; 112:169-180